OBJECTIVE: Timely initiation of combination antiretroviral therapy (ART) limits latent HIV reservoir size and should also limit reservoir genetic complexity. However, the relationship between these two factors remains unclear, particularly among HIV-infected youth. DESIGN: Retrospective analysis of replication-competent latent HIV clones serially isolated by limiting-dilution culture from resting CD4 T-cell reservoirs from ART-suppressed, young adult participants of a historic phase I therapeutic vaccine trial (PACTG/IMPAACT-P1059). METHODS: Replication-competent latent HIV clones isolated from resting CD4 T cells of four perinatally and 10 nonperinatally infected young adults (average 22 versus 6 years uncontrolled infection, respectively) were sequenced in Pol and Nef. Within-host HIV sequence datasets were characterized with respect to their genetic diversity and inferred immune escape mutation burden. RESULTS: Although participants were comparable in terms of sociodemographic and HIV sampling characteristics (e.g. on average, a mean 17 Pol sequences were recovered at five timepoints over up to 70 weeks) and the length of ART suppression at study entry (average 3 years), replication-competent HIV reservoir size, genetic diversity, immune escape mutation burden and variant complexity were significantly higher among the perinatally infected participants who experienced longer durations of uncontrolled viremia. Nevertheless, viral sequences inferred to retain susceptibility to host cellular immune responses were detected in all participants, irrespective of uncontrolled viremia duration. CONCLUSION: HIV elimination in late-suppressed youth may be doubly challenged by larger and more genetically complex reservoirs. Strategies that integrate host and viral genetic complexity to achieve HIV remission or cure may merit consideration in such cases.
OBJECTIVE: Timely initiation of combination antiretroviral therapy (ART) limits latent HIV reservoir size and should also limit reservoir genetic complexity. However, the relationship between these two factors remains unclear, particularly among HIV-infected youth. DESIGN: Retrospective analysis of replication-competent latent HIV clones serially isolated by limiting-dilution culture from resting CD4 T-cell reservoirs from ART-suppressed, young adult participants of a historic phase I therapeutic vaccine trial (PACTG/IMPAACT-P1059). METHODS: Replication-competent latent HIV clones isolated from resting CD4 T cells of four perinatally and 10 nonperinatally infected young adults (average 22 versus 6 years uncontrolled infection, respectively) were sequenced in Pol and Nef. Within-host HIV sequence datasets were characterized with respect to their genetic diversity and inferred immune escape mutation burden. RESULTS: Although participants were comparable in terms of sociodemographic and HIV sampling characteristics (e.g. on average, a mean 17 Pol sequences were recovered at five timepoints over up to 70 weeks) and the length of ART suppression at study entry (average 3 years), replication-competent HIV reservoir size, genetic diversity, immune escape mutation burden and variant complexity were significantly higher among the perinatally infected participants who experienced longer durations of uncontrolled viremia. Nevertheless, viral sequences inferred to retain susceptibility to host cellular immune responses were detected in all participants, irrespective of uncontrolled viremia duration. CONCLUSION: HIV elimination in late-suppressed youth may be doubly challenged by larger and more genetically complex reservoirs. Strategies that integrate host and viral genetic complexity to achieve HIV remission or cure may merit consideration in such cases.
Authors: Zheng Wang; Evelyn E Gurule; Timothy P Brennan; Jeffrey M Gerold; Kyungyoon J Kwon; Nina N Hosmane; Mithra R Kumar; Subul A Beg; Adam A Capoferri; Stuart C Ray; Ya-Chi Ho; Alison L Hill; Janet D Siliciano; Robert F Siliciano Journal: Proc Natl Acad Sci U S A Date: 2018-02-26 Impact factor: 11.205
Authors: Vivek Jain; Wendy Hartogensis; Peter Bacchetti; Peter W Hunt; Hiroyu Hatano; Elizabeth Sinclair; Lorrie Epling; Tzong-Hae Lee; Michael P Busch; Joseph M McCune; Christopher D Pilcher; Frederick M Hecht; Steven G Deeks Journal: J Infect Dis Date: 2013-07-12 Impact factor: 5.226
Authors: Nicolas Chomont; Mohamed El-Far; Petronela Ancuta; Lydie Trautmann; Francesco A Procopio; Bader Yassine-Diab; Geneviève Boucher; Mohamed-Rachid Boulassel; Georges Ghattas; Jason M Brenchley; Timothy W Schacker; Brenna J Hill; Daniel C Douek; Jean-Pierre Routy; Elias K Haddad; Rafick-Pierre Sékaly Journal: Nat Med Date: 2009-06-21 Impact factor: 53.440
Authors: Deborah Persaud; Stuart C Ray; Joleen Kajdas; Aima Ahonkhai; George K Siberry; Kimberly Ferguson; Carrie Ziemniak; Thomas C Quinn; Joseph P Casazza; Steven Zeichner; Stephen J Gange; Douglas C Watson Journal: AIDS Res Hum Retroviruses Date: 2007-03 Impact factor: 2.205
Authors: Marta Martínez-Bonet; Maria Carmen Puertas; Claudia Fortuny; Dan Ouchi; Maria José Mellado; Pablo Rojo; Antoni Noguera-Julian; Ma Angeles Muñoz-Fernández; Javier Martinez-Picado Journal: Clin Infect Dis Date: 2015-06-10 Impact factor: 9.079
Authors: Lina Josefsson; Susanne von Stockenstrom; Nuno R Faria; Elizabeth Sinclair; Peter Bacchetti; Maudi Killian; Lorrie Epling; Alice Tan; Terence Ho; Philippe Lemey; Wei Shao; Peter W Hunt; Ma Somsouk; Will Wylie; Daniel C Douek; Lisa Loeb; Jeff Custer; Rebecca Hoh; Lauren Poole; Steven G Deeks; Frederick Hecht; Sarah Palmer Journal: Proc Natl Acad Sci U S A Date: 2013-11-25 Impact factor: 11.205
Authors: Bradley R Jones; Natalie N Kinloch; Joshua Horacsek; Bruce Ganase; Marianne Harris; P Richard Harrigan; R Brad Jones; Mark A Brockman; Jeffrey B Joy; Art F Y Poon; Zabrina L Brumme Journal: Proc Natl Acad Sci U S A Date: 2018-09-05 Impact factor: 11.205
Authors: Santiago Avila-Rios; Jonathan M Carlson; Mina John; Simon Mallal; Zabrina L Brumme Journal: Curr Opin HIV AIDS Date: 2019-05 Impact factor: 4.283
Authors: Rachel L Miller; Rosalie Ponte; Zabrina L Brumme; Jean-Pierre Routy; Bradley R Jones; Natalie N Kinloch; Fredrick H Omondi; Mohammad-Ali Jenabian; Franck P Dupuy; Remi Fromentin; Pierre Brassard; Vikram Mehraj; Nicolas Chomont; Art F Y Poon; Jeffrey B Joy Journal: J Virol Date: 2019-08-13 Impact factor: 5.103
Authors: F Harrison Omondi; Hanwei Sudderuddin; Aniqa Shahid; Natalie N Kinloch; Bradley R Jones; Rachel L Miller; Olivia Tsai; Daniel MacMillan; Alicja Trocha; Mark A Brockman; Chanson J Brumme; Jeffrey B Joy; Richard Liang; Bruce D Walker; Zabrina L Brumme Journal: mBio Date: 2021-11-16 Impact factor: 7.867
Authors: Andrew Wilson; Leyn Shakhtour; Adam Ward; Yanqin Ren; Melina Recarey; Eva Stevenson; Maria Korom; Colin Kovacs; Erika Benko; R Brad Jones; Rebecca M Lynch Journal: Front Immunol Date: 2021-09-15 Impact factor: 7.561
Authors: Marilia R Pinzone; Sam Weissman; Alexander O Pasternak; Ryan Zurakowski; Stephen Migueles; Una O'Doherty Journal: JCI Insight Date: 2021-08-23